Objectives: Congenital renal arteriovenous malformations (rAVMs) represent rare vascular diseases. The heterogeneous vascular architecture of each rAVM determines the endovascular treatment techniques employed. We reported our experience with the endovascular treatment of a series of rAVMs. Materials: This retrospective study consisted of 12 patients with 12 rAVMs who underwent renal arterial embolization (RAE) in our hospital. Embolic materials, including particles, liquid embolic agents (n-butyl 2-cyanoacrylate, Onyx, and ethanol), and coils, were selectively used based on the decisions of interventional radiologists. Technical success was defined as the complete occlusion of the feeding arteries and nidus on postprocedure renal arteriography. Clinical success was defined as the resolution of hematuria or the disappearance of rAVM-relevant symptoms.
Introduction
Renal arteriovenous malformations (rAVMs) are rare and heterogeneous vascular abnormalities between arteries and veins without intervening capillaries. Pathologic shunting of blood from the arterial to the venous side may cause massive hematuria, pain, and heart failure. [1] [2] [3] [4] Congenital rAVMs could be classified into 3 types according to the classification of arteriovenous (AV) malformations in the extremities and body trunk. 5 Type I AVMs include fewer than 4 separate arteries shunting to a single draining vein, type II AVMs include multiple arterioles that shunt to a single draining vein, and type III AVMs include multiple fine arteriovenous fistulas. Computed tomography (CT) angiography (CTA) is sensitive for the detection of rAVMs, whereas selective renal arteriography reveals the vascular architecture in detail as well as hemodynamics. 1, 2 Renal arterial embolization (RAE) is the preferred treatment for rAVMs with various embolic materials and has demonstrated good outcomes. 2, 4, 610 However, primary or congenital rAVMs are extremely rare, and the angioarchitecture and hemodynamic profiles of each rAVM differ from each other. Here, we present a series of patients with congenital rAVMs. Some of these patients exhibit peculiar presentations that have not been reported previously, and we present our experience with the endovascular treatment of rAVMs.
Materials and Methods Patients
Between May 2009 and October 2016, 12 patients with 12 rAVMs (5 women and 7 men; mean age, 53.3 years; age range, 38-65 years) received 12 RAEs in our hospital. Patients' medical records were reviewed for symptoms and baseline renal function (blood creatinine [Cr] ). Radiologic images were reviewed. All patients had no medical history suggesting acquired rAVMs, such as biopsy, partial nephrectomy, or extracorporeal shock wave lithotripsy for urinary stones. Informed consent for the procedure was obtained from each patient, whereas informed consent for data use was waived, given the retrospective study design. The ethics committee of our institute approved the study.
Angiographic Findings and Embolization Technique
The right common femoral artery was routinely accessed with a 5F sheath. Selective catheterization of the renal artery was performed with a 5F catheter (Cobra, Cook, Bloomington, Indiana) for renal arteriography. The contrast injection rate for renal angiogram was typically set at 5 to 7 mL/s with a total volume of 10 to 15 mL. We defined the high-flow rAVMs, as the draining vein opacified before the staining of the renal parenchyma; otherwise, it was defined as low-flow rAVMs. Each rAVM was classified as 1 of 3 types (I, II, and III) according to the scheme of angiographic classification of AV malformations by Cho et al. 5 The number of segmental arteries from which the abnormal feeding arteries arose was recorded. The abnormal feeding arteries entering into the nidus were divided into proximal feeders and distal feeders. The proximal feeders were defined as branches arising from the proximal portion of segmental renal arteries that exhibited difficulties upon super selective catheterization with microcatheters. If the parent artery was sacrificed (occluded), the entire renal segment would become infarct. The distal feeders were defined as branches arising from the distal part of segmental renal arteries that may or may not be superselectively catheterized. If the segmental artery was sacrificed, only a small portion of the renal segment would become infarcted.
A microcatheter (Progreat, Terumo Corporation, Ashitaka, Japan; or Echelon-10, Medtronic, Minneapolis, Minnesota) was advanced into identifiable target vessels for transarterial embolization. Embolic materials, including gelatin-sponge particles (GSP), polyvinyl alcohol (PVA), n-butyl 2-cyanoacrylate (NBCA; TRUFILL; Codman Neuro, Raynham, MA, USA), Onyx (Onyx 18; COVIDIEN, Irvine, CA, USA), and coils were selectively used based on the decisions of interventional radiologists. In all procedures, the level of embolization was restricted to no higher than the segmental artery. After the procedure, final renal arteriogram was performed to evaluate the occlusion of target vessels and the infarcted renal area of the affected kidney.
Study End Points
Technical success was defined as the complete occlusion of the feeding arteries and rAVM nidus on postprocedure renal arteriography. Each patient was advised to undergo urine assessment in a local hospital 2 weeks after discharge from our hospital and report the results to our attending nurse. Postoperative surveillance was performed through telephone follow-up in October 2016. Clinical success was defined as the resolution of hematuria or the disappearance of rAVM-relevant symptoms.
Results

Patient Characteristics
All lesions were unilateral with 5 (41.7%) rAVMs located in right kidneys. Clinical characteristics of the patients and procedure outcomes are summarized in Table 1 . Of the 12 patients, 10 patients presented with gross hematuria, 1 patient presented with left scrotum swelling, and 1 patient was asymptomatic. Patient no. 9 received RAE once at another hospital and received a second RAE in our hospital for recurrent hematuria. Seven patients were given the diagnosis of rAVMs using CTA. Five patients underwent non-contrast-enhanced CT and ultrasound with suspect of rAVMs. Subsequently, a final diagnosis of rAVMs was made by renal arteriography in all the 12 patients. Two patients had type I rAVMs, 5 had type II rAVMs, and 5 had type III rAVMs.
Renal Arterial Embolization
Single embolic material NBCA, Onyx, coils, and PVA were used in 3 (25%), 1 (8.3%), 1 (8.3%), and 1 (8.3%) procedures, respectively. Various combinations of embolic materials, including coils and particles (PVA or GSP), coils and NBCA, and coils and ethanol, were used in 5 (41.7%), 2 (16.7%), 1 (8.3%), and 1 (8.3%) procedures, respectively. The NBCA was diluted to a concentration of 25% with iodized oil (Lipiodol; Andre Guerbet, Aulnay-Sous-Bois, France). The size of GSP or PVA particles ranged from 300 to 700 mm.
Outcome
The median follow-up period from procedures was 13.5 (range, 4-72) months. No hematuria (presence of 5 or more red blood cells per high-power field) was reported by the patients 2 weeks after the discharge from our hospital. The technical success based on 12 procedures in 12 patients was 83.3% (10 of 12). In 2 procedures (no. 8 and no. 10) that technically failed, numerous fine feeding arteries derived from segmental arteries near the main renal artery bifurcation were impossible to be superselectively catheterized. Complete occlusion of nidus may require sacrificing the parent artery and inducing a large area renal infarction. Thus, some feeders were spared (no. 10; Figure 1 ). Patient no. 10 achieved clinical success without additional RAE, whereas patient no. 8 had minor recurrent hematuria 25 months after the initial treatment, which was successfully managed with hemostatic drugs.
One peculiar case (no. 4; Figure 2 ) was noted who primarily presented with left scrotum swelling. Renal arteriography of the patient revealed high-flow renal AV shunts, left renal vein stenosis, and blood reflux into a left spermatic vein. The rAVMs were embolized successfully in the first session, but the symptom of left scrotum swelling did not disappear. Therefore, the patient underwent balloon dilation of left renal vein and embolization of left spermatic vein with coils in the second session. Then, the symptom disappeared. Given that the symptom that persisted after the first session was not caused by rAVMs, we defined this case as a technical and clinical success.
During the procedure in patient no. 9 (type III), some NBCA was observed flowing into the draining vein. Thus, coils were used first to reduce the blood flow. Then, NBCA was used to embolize the rAVMs. Although pulmonary embolism was suspected, no fluctuation of oxygen saturation was observed during and after the procedure (Figure 3) .
In the 12 patients, the infarcted renal areas ranged from 0.0% to 40.4% (mean, 20.3%). Renal infarction was not evident in a patient (no. 1) with renal AVF (single feeding artery and coil embolization). In the patients with numerous fine feeding arteries arising from different segmental arteries, the infarcted renal area was increased compared to the others. In all patients, no significant difference in serum creatinine levels was observed before and after treatment. Four patients (no. 8, 10, 11, and 12) complained of mild discomfort in the flank of the affected side, which disappeared within 3 days.
Discussion
Renal AVM typically presents as hematuria initially and is a therapeutic challenge due to its deep location in the renal parenchyma. 11 The present study revealed that renal artery embolization is an effective treatment for rAVMs, whereas the existence of multiple fine feeding vessels arising from the proximal portion of different segmental renal arteries is one cause of incomplete embolization.
For rAVMs with multiple feeding arteries, an accurate evaluation of the vascular architecture was helpful in treatment planning and embolization material selection. Although digital subtraction angiography is the gold standard in the diagnosis of vascular disease, 12 some fine feeding arteries of rAVMs cannot be clearly identified in the initial arteriography, which will become evident after the occlusion of overt feeding arteries (Figure 1) . Therefore, the initial renal arteriography should be performed with high magnification to reveal vascular structure details, and the embolization protocol should be modified according to the arteriography during the procedure.
Various embolic materials can be used to occlude rAVMs.
1,2,4,6 Renal AV shunts with high blood flow should be embolized with coils first to reduce the blood flow velocity and then embolized with NBCA to achieve a complete embolization. 1 It is difficult to achieve complete occlusion with coils alone due to the small gaps in the coils. It is infeasible to occlude the shunts with NBCA alone because the liquid embolic material would be washed away by the high blood flow without the blocking provided by coils. For low-flow rAVMs, a wide range of embolic materials is available. A combination of particles (GSP and PVA), NBCA, ethanol, and coils are feasible. NBCA and Onyx are liquid embolic agents that can penetrate into the nidus of rAVMs to achieve complete embolization. 3, 4 Ethanol is another liquid embolic agent. Hwang et al reported that congenital renal AVMs could be embolized with ethanol and coils effectively. 2 Compared with NBCA and Onyx, ethanol is inexpensive and does not require changing microcatheters after each embolization. However, no study has been performed to compare the efficacy and side effects of these liquid embolic agents in the treatment of rAVMs. Particles remain the most used embolic materials used in the embolization of rAVMs. 4, 6, 9, 13 Given the high rate of recanalization, each feeding artery was typically embolized with particles first followed by coils to achieve permanent embolization. Regarding rAVMs with large fistulas, small-sized particles should not be used, given the risk of pulmonary embolization. In some situations, 1 patient with rAVMs may be eligible for the treatment with ethanol, NBCA, or coils and particles. Based on the vasculature and hemodynamic profiles of each rAVM, the operators may choose the embolic materials that they are familiar with to obtain complete embolization of rAVMs.
In the present study, technical failure was mainly attributed to the existence of multiple proximal feeding arteries, and similar cases were also reported in several previous studies. 2, 4, 14 The difficulty in this type of patient is that trying to embolize the multiple proximal feeders will cause a large area of renal parenchyma infarction, leading to loss of renal function and severe postoperative pain. The current opinion is that even partial embolization may occlude some risk branches and reduce blood pressure in the rAVMs, which may lead to clinical success or reduce the severity of recurrent hematuria. 4 Case no. 4 with persistent left scrotum swelling after successful rAVMs embolization is interesting (Figure 2) . We hypothesized that the high-flow AV shunts induced renal vein stenosis, and the high pressure in the renal vein resulted in dilation of the left spermatic vein with blood reflux. Renal vein pressure could not be reduced to normal by embolization the rAVMs alone until the renal vein stenosis was relieved. In contrast to the common symptoms of rAVMs, such as Figure 1 . Multiple feeding arteries lead to technical failure (patient no. 10). A, Right renal arteriography reveals multiple fine feeding arteries that enter into the nidus. B-E, Four branches of feeding arteries were embolized individually with n-butyl 2-cyanoacrylate (NBCA; 25%, 1.3 mL) and polyvinyl alcohol (PVA) particles. F, Final right renal arteriography reveals some residual fine feeding arteries that were not identified on the initial arteriography (short arrows), the opacification of nidus (long arrow), and the infarct area (arrow heads).
hematuria, flank pain, or heart failure, this case suggested that high-flow rAVM might also cause renal vein stenosis and thus renal vein hypertension-related symptoms. In addition, these findings indicate that the venous phase of renal arterial angiography should be carefully evaluated to exclude secondary changes.
This study had several limitations. First, rAVMs are rare and heterogeneous vascular abnormalities. The treatment protocol differs from case to case, so the efficacy of different treatment methods cannot be compared. Second, for rAVMs with multiple feeding arteries and a single large draining vein (no. 10; Figure 1 ), a direct percutaneous puncture of the dilated vein and embolization with coils may help ensure technical success when transarterial embolization cannot cure the rAVM. 2 Third, for high-flow rAVMs (no.1, 4, and 9), a flow-control technique with balloon catheter occluding proximal portion of the renal artery may assist safe and effective embolization by avoiding the liquid embolic materials being flushed into draining vein prior to its solidification. 1 Fourth, we only measured infarcted renal area on final renal arteriogram, which cannot show the renal function change as dimercaptosuccinic acid scan. Further studies should pay attention to this aspect.
Conclusion
Renal artery embolization is an effective treatment for patients with rAVMs. The selection of embolic materials should be based on the vasculature and hemodynamic profiles of each rAVM. The existence of multiple fine feeding vessels arising from the proximal portion of different segmental renal arteries appears to be one risk factor for technical failure.
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